Table 3.
Stressor agent | Ischemia nuclear-study | Ischemic changes-EKG | Sensitivity | Specificity | PPV | NPV |
---|---|---|---|---|---|---|
Regadenoson | 43 (21.7%) | 31 (15.7%) | 7% | 81.9% | 9.7% | 76.0% |
Adenosine | 28 (17.9%) | 16 (10.2) | 10.7% | 89.8% | 18.8% | 82.1% |
Stressor agent | Ischemia nuclear-study | Ischemic changes-EKG | Sensitivity | Specificity | PPV | NPV |
---|---|---|---|---|---|---|
Regadenoson | 43 (21.7%) | 31 (15.7%) | 7% | 81.9% | 9.7% | 76.0% |
Adenosine | 28 (17.9%) | 16 (10.2) | 10.7% | 89.8% | 18.8% | 82.1% |